Protocol to Validate the Performance of the Mellitus Glycated CD59 ELISA for Gestational Diabetes Screening
Public ClinicalTrials.gov record NCT03865901. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
Subject Enrollment and Specimen Collection Protocol to Validate the Performance of the Mellitus GCD59 ELISA for Gestational Diabetes Screening
Brief summary
Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.
Demonstrate effective performance of the Mellitus GCD59 Test (an ELISA) in screening for gestational diabetes mellitus (GDM)
Study identification
- NCT ID
- NCT03865901
- Recruitment status
- Withdrawn
- Study type
- Observational
- Phase
- Not listed
- Enrollment
- Not listed
Conditions and interventions
Conditions
Eligibility (public fields only)
- Age range
- 18 Years and older
- Sex
- Female
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Apr 30, 2019
- Primary completion
- Apr 30, 2020
- Completion
- Aug 31, 2020
- Last update posted
- Sep 16, 2019
2019 – 2020
United States locations
- U.S. sites
- 19
- U.S. states
- 14
- U.S. cities
- 19
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| University of Alabama | Birmingham | Alabama | 35294 | — |
| UC Irvine Health | Orange | California | 92868 | — |
| University of Colorado Anschutz Medical Campus | Aurora | Colorado | 80045 | — |
| Christina Care Health System | Newark | Delaware | 19713 | — |
| Johns Hopkins University | Baltimore | Maryland | 21287 | — |
| Boston Medical Center | Boston | Massachusetts | 02118 | — |
| UMass Medical School/UMass Memorial Health Care | Worcester | Massachusetts | 01605 | — |
| Spectrum Hleath | Grand Rapids | Michigan | 49503 | — |
| University of North Carolina, Chapel Hill | Chapel Hill | North Carolina | 27599 | — |
| MetroHealth Medical Center | Cleveland | Ohio | 44109 | — |
| Ohio State University School of Medicine | Columbus | Ohio | 43209 | — |
| University of Pennsylvania | Philadelphia | Pennsylvania | 19104 | — |
| Greenville Health System | Greenville | South Carolina | 29605 | — |
| Austin Maternal-Fetal Medicine | Austin | Texas | 78758 | — |
| University of Texas Medical Branch | Galveston | Texas | 77555 | — |
| Baylor College of Medicine | Houston | Texas | 77401 | — |
| University of Texas Health Science Center, San Antonio | San Antonio | Texas | 78207 | — |
| University of Utah School of Medicine | Salt Lake City | Utah | 84132 | — |
| Eastern Virginia Medical School | Norfolk | Virginia | 23507 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT03865901, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Sep 16, 2019 · Synced Sep 15, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete protocol, eligibility criteria, and contact information for NCT03865901 live on ClinicalTrials.gov.